221 related articles for article (PubMed ID: 11451209)
21. Clinical use of tumor markers in oncology.
Jacobs EL; Haskell CM
Curr Probl Cancer; 1991; 15(6):299-360. PubMed ID: 1760927
[TBL] [Abstract][Full Text] [Related]
22. [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
Pejcić I; Vrbić S; Filipović S; Sćekić M; Petković I; Pejcić L; Djenić N
Vojnosanit Pregl; 2010 Sep; 67(9):723-31. PubMed ID: 20954411
[TBL] [Abstract][Full Text] [Related]
23. Alpha-fetoprotein and beta-human chorionic gonadotropin: their clinical significance as tumour markers.
Gregory JJ; Finlay JL
Drugs; 1999 Apr; 57(4):463-7. PubMed ID: 10235686
[TBL] [Abstract][Full Text] [Related]
24. Predictive markers in breast and other cancers: a review.
Duffy MJ
Clin Chem; 2005 Mar; 51(3):494-503. PubMed ID: 15637130
[TBL] [Abstract][Full Text] [Related]
25. Biomarker development, from bench to bedside.
Stenman UH
Crit Rev Clin Lab Sci; 2016; 53(2):69-86. PubMed ID: 26287282
[TBL] [Abstract][Full Text] [Related]
26. Biochemical markers in breast cancer: which ones are clinically useful?
Duffy MJ
Clin Biochem; 2001 Jul; 34(5):347-52. PubMed ID: 11522269
[TBL] [Abstract][Full Text] [Related]
27. [Tumor markers in testicular cancer].
Mann K
Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
[TBL] [Abstract][Full Text] [Related]
28. Tumor markers in breast cancer--evaluation of their clinical usefulness.
Marić P; Ozretić P; Levanat S; Oresković S; Antunac K; Beketić-Oresković L
Coll Antropol; 2011 Mar; 35(1):241-7. PubMed ID: 21661378
[TBL] [Abstract][Full Text] [Related]
29. New tumor markers: CA125 and beyond.
Bast RC; Badgwell D; Lu Z; Marquez R; Rosen D; Liu J; Baggerly KA; Atkinson EN; Skates S; Zhang Z; Lokshin A; Menon U; Jacobs I; Lu K
Int J Gynecol Cancer; 2005; 15 Suppl 3():274-81. PubMed ID: 16343244
[TBL] [Abstract][Full Text] [Related]
30. Status of tumor markers in ovarian cancer screening.
Bast RC
J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135
[TBL] [Abstract][Full Text] [Related]
31. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
Oesterling JE
J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
[TBL] [Abstract][Full Text] [Related]
32. CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use.
Duffy MJ; Bonfrer JM; Kulpa J; Rustin GJ; Soletormos G; Torre GC; Tuxen MK; Zwirner M
Int J Gynecol Cancer; 2005; 15(5):679-91. PubMed ID: 16174214
[TBL] [Abstract][Full Text] [Related]
33. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
34. Perspectives on the future of cancer markers.
Bast RC
Clin Chem; 1993 Nov; 39(11 Pt 2):2444-51. PubMed ID: 8222257
[TBL] [Abstract][Full Text] [Related]
35. Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies.
Duffy MJ
Clin Chem; 2002 Aug; 48(8):1194-7. PubMed ID: 12142372
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
37. Human tetranectin: methodological and clinical studies.
Høgdall CK
APMIS Suppl; 1998; 86():1-31. PubMed ID: 9868384
[TBL] [Abstract][Full Text] [Related]
38. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
Watson AP; Egland KA
S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
[TBL] [Abstract][Full Text] [Related]
39. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
[TBL] [Abstract][Full Text] [Related]
40. Serum tumor markers in chronic kidney disease: as clinical tool in diagnosis, treatment and prognosis of cancers.
Amiri FS
Ren Fail; 2016; 38(4):530-44. PubMed ID: 26907957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
